OCTOBIDPublic Tender GazetteHEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Grant monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- Grant
- Solicitation number
- RFA-NS-27-007
- Posted
- June 16, 2026
- Response deadline
- February 20, 2029
- Location
- US
- Estimated value
- $11,000,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
The purpose of this Notice of Funding Opportunity (NOFO) is to support the preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics for the treatment of pain. The goal of the program is to accelerate the advancement of promising early-stage therapeutic candidates and facilitate their readiness for Phase II clinical trials. Applicants must have a promising small molecule or biologic lead candidate for optimization,…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.